Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

153 trials

NCT07583823
Recruiting
Elevated Rate Pacing of Cardiac Amyloidosis
Not applicable · United States · 1 site
Registry update: 13 Oct 2026
NCT07207811
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Ireland, Italy, Japan, South Korea, Netherlands, Poland, Sweden, United States · 298 sites
Registry update: 21 Oct 2026
NCT07306949
Recruiting
Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Phase 4 · Japan · 15 sites
Registry update: 7 Jan 2026
NCT07172243
Recruiting
BE.Amycon Biobank & Data Registry UZ Leuven
Not applicable · Belgium · 2 sites
Registry update: 25 Sept 2026
NCT07215715
Recruiting
US Benchmarking Clinical Study
Not applicable · United States · 3 sites
Registry update: 20 Oct 2025
NCT06974877
Recruiting
Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
Phase 1 · United States · 1 site
Registry update: 19 May 2026
NCT07151690
Recruiting
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
Phase 2 · China · 1 site
Registry update: 23 Jul 2026
NCT07081646
Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Phase 1/2 · Canada, United Kingdom, United States · 13 sites
Registry update: 2 Jul 2026
NCT07039578
Recruiting
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
Phase 2 · China · 2 sites
Registry update: 26 Nov 2025
NCT07232459
Recruiting
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
Not applicable · China · 3 sites
Registry update: 8 Sept 2026
NCT07052903
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Phase 3 · Argentina, Austria, Australia, Belgium, Brazil, Canada, Switzerland, Chile, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, South Korea, Mexico, Malaysia, Netherlands, Norway, New Zealand, Poland, Portugal, Romania, Sweden, Slovakia, Taiwan, United States · 244 sites
Registry update: 20 Oct 2026
NCT07079423
Recruiting
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
Phase 2 · China · 1 site
Registry update: 23 Jul 2025
NCT07085559
Recruiting
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Early phase 1 · China · 1 site
Registry update: 25 Jul 2025
NCT06940336
Recruiting
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Phase 4 · China · 1 site
Registry update: 30 Jul 2025
NCT06978660
Recruiting
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
Not applicable · Germany, Spain, France, United Kingdom, United States · 8 sites
Registry update: 4 Nov 2026
NCT06845644
Recruiting
Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients
Not applicable · France · 1 site
Registry update: 29 Oct 2026
NCT06935162
Recruiting
Teclistamab in Previously Treated AL Amyloidosis
Phase 2 · China · 1 site
Registry update: 25 May 2025
NCT06563895
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Phase 3 · Argentina, Australia, Belgium, Bulgaria, Brazil, Canada, Germany, Denmark, Spain, France, United Kingdom, Greece, Ireland, Italy, Japan, South Korea, Martinique, Mexico, Malaysia, Netherlands, Portugal, Sweden, Singapore, Taiwan, United States · 107 sites
Registry update: 4 Aug 2026
NCT06699394
Recruiting
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
Not applicable · China · 2 sites
Registry update: 24 Apr 2025
NCT06998875
Recruiting
A Prospective Cohort Study on Primary Cutaneous Amyloidosis
Phase 4 · China · 1 site
Registry update: 13 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.